About Dana Fowlkes
This author has not written his bio yet.
But we are proud to say that Dana Fowlkes contributed 47 entries already.
Entries by Dana Fowlkes
The Beginninng of the End of the Pandemic Era
The global scientific and technical response to the Covid-19 pandemic illustrates the power of 21st century medical science and technology. Clearly, a goal, based upon that we’ve learned, can be and should be the elimination of future pandemics. While Evrys Bio’s daily work is on the development of therapeutics for a broad range of viral […]
Advancing new tools for infectious diseases: Therapeutics and vaccine development for infectious diseases could be transformed
Therapeutics and vaccine development for infectious diseases could be transformed according to Viewpoint published in Science this week by Rajesh Gupta (SCIENCE20 NOV 2020 : 913-914)* Please read the whole article for a look a modern approach to infectious diseases here: SCIENCE 20 NOV 2020
Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool
Amesh Adaljaa of the Center for Health Security, Johns Hopkins Bloomberg School of Public Health and Thomas Inglesby of the Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA wrote a editorial in EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019, VOL. 17, NO. 7, 467–470) spelling out the need […]
Evrys Bio’s CEO Lillian Chiang to address NIH SARS-CoV-2 Antiviral Therapeutics Summit
Evrys Bio’s CEO Lillian Chiang will address the topic “Are there broad spectrum modalities for targeting SARS-CoV-2 that could be useful against other viruses and thus for future pandemic response?” at the upcoming NIH Symposium scheduled for Friday, November 6, 2020 11:00 AM – 3:30 PM Eastern Time
Inhibition of Sirtuins is Broadly Effective Against Coronaviruses
On October 7, 2020, staff scientist Dr. Liudi Tang presented at the Special isirv-AVG Virtual Conference on ‘Therapeutics for COVID-19’ . Dr. Tang will present the most recent data for one of Evrys Bio’s drug leads which has been demonstrated to have a broad spectrum of activities against a variety of viruses involved in human […]
Evrys Bio’s CEO Chiang presents at upcoming Bio-NJ virtual conference
Tuesday, October 6 and Wednesday, October 7, Evrys Bio will be represented at the premier mid-Atlantic biotech and pharmaceutical partnering conference. Dr. Lillian Chiang, CEO and Dana Fowlkes, CBO will be representing Evrys Bio. This virtual conference has been extended to a total of four days to permit more opportunities for one on one partnering […]
Gov. Wolf awards $1.1 million to biotech center in Buckingham for COVID-19 work
Pennsylvania Biotechnology Center of Bucks County is once again in the spotlight, this time as the recipient of more than $1 million in state grants to help with research in pursuing a treatment and vaccine for COVID-19. Of 23 state awards, the biotechnology center, located next to the Doylestown Airport in Buckingham, received four grants, bringing in $1.1 million […]
Pennsylvania Awards $10 Million to 23 Entities
Governor Tom Wolf announced that 23 awardees will receive $10 million in grant funding through the COVID-19 Vaccines, Treatments and Therapies (CV-VTT) program to support the rapid advancement of vaccines, treatments and therapies by qualified biotechnology entities in response to the COVID-19 pandemic. Evrys Bio was awarded over $300,000 to develop treatments for virus caused […]
Evrys Bio awarded a supplement to its NIH National Institute for Allergy and Infectious Disease titled, “A Single Antiviral to Treat Multiple Opportunistic Infections”
July 22, 2020: In response to emergency research funding for COVID-19, the supplement extends testing of Evrys broad-spectrum antivirals to coronaviruses including SRAS-CoV-2. ABSTRACT
Sitemap
Evrys Bio
3805 Old Easton Road
Doylestown, PA 18902
Federal Conflict of Interest Policy Statement
View the FCOI POL_0006 FCOI_1_0
pertaining to federally funded projects
